Kratom & kava guides
How to Verify MIT Tablets and Extracts During the 7-OH Scheduling Process
Before buying an MIT tablet or extract powder, make six checks: the active compound, product form, lot or sample, label strength, laboratory results, and current law. “Kratom extract” or “7-OH alternative” does not provide those details.
1. Name the active
MIT means mitragynine. 7-hydroxymitragynine, mitragynine pseudoindoxyl, MGM-15, and MGM-16 are separate compounds, regardless of similar packaging or a shared tablet format.
2. Name the form
A tablet is counted by unit; extract powder is sold by weight. Keep a milligram-per-tablet result separate from a percentage or milligram-per-gram powder result.
3. Find the matching lot or sample
- Use the complete report rather than a badge.
- Match the product or material description.
- Record the sample or lot ID and report date.
- Identify whether the laboratory tested a tablet, gummy, or source material.
- Read each analyte with its result, unit, LOD/LOQ, and notes.
4. Read the label and measured result separately
Mango MIT Tablets contain 150mg of mitragynine per tablet; lot M/150/002 lab tested at 146mg per tablet. MIT 90% Extract Powder has a 90% mitragynine specification; source-material sample DD00126B(15) lab tested at 87.01% mitragynine.
5. Interpret 7-OH and MGM fields precisely
“Not detected” means the laboratory found no reportable amount under that method and its method limits. It does not prove absolute zero, and the result applies only to the submitted source sample.
6. Check current law separately
MGPI, MGM-15, and MGM-16 are temporarily Schedule I as of August 26, 2026. The separate 7-OH threshold proposal remains pending as of September 19. The August order names three compounds; MIT status, FDA requirements, and state law require their own checks.
MIT product documents and COAs